A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction.
Sunil V RaoBodo KirschDeepak L BhattAndrzej BudajRosa CoppolecchiaJohn William EikelboomStefan K JamesW Schuyler JonesBela MerkelyLars KellerRenicus S HermanidesGianluca Calogero CampoJosé Luis FerreiroTaro ShibasakiHardi MundlJohn H Alexandernull nullPublished in: Circulation (2022)
gov; Unique identifier: NCT04304534; URL: https://www.clinicaltrialsregister.eu/ctr-search/search; Unique identifier: 2019-003244-79.